Press Releases

To see only press releases which have been disclosed pursuant to legislation or other regulations, please select “Regulatory releases” below.


Business highlights in Q1 2023 In March the Company announced the completion of dosing of all 24 patients the the Phase IIa clinical trial with IP2018 and that preliminary results are expected end…

Last day of trading in BTA in Initiator Pharma

Initiator Pharma A/S (“Initiator Pharma” or “the Company”) rights issue has now been registered with the Danish Companies Registration Office. The Company hereby announces that the last day of trading in paid subscribed shares (Sw. BTA) will be on 21 July 2022 and stop day will be on 25 July 2022.